| 联系我们 |
|
欢迎联系客服人员：
客服：13918293035
QQ：3001034031
客服：13917991872
QQ：3001005926
客服：15102117276
QQ：3001090745
客服：18217024652
QQ：3001084617
客服：13816009161
QQ：3001086693
客服：13795317828
QQ：3001080377
客服：15800340161
QQ：3001010259
客服：13651665725
QQ：3001028570
客服：18918753302
QQ：3001080321
客服：13916577892
QQ：3001007248
客服：15316187026
QQ：3004961006
客服：18901678489
QQ：3004909899
客服：18018502489
QQ：3004930012
客服：18019219489
QQ：3004900398
电话：021-58979353
电话：021-68920155
电话：021-68404353
邮箱：info@zzsrm.com
邮箱：tech@zzbioco.com
|
|
|
| 产品中心当前位置：首 页 > 产品中心 > 全部产品 |
| 货号 |
中文名称 |
CAS编号 |
产品规格 |
价格 |
货期 |
| ZUP-1A05830 |
4-氯-3-(三氟甲基)苯胺 USP标准品 |
[320-51-4] |
1unit |
10710 |
约6周 |
|
| ZUP-1606401 |
卢非酰胺 USP标准品 |
[106308-44-5] |
1unit |
10696 |
约6周 |
|
| ZUP-1A02710 |
危险品; 顺苯磺酸阿曲库铵顺-季酸 |
[1075727-06-8] |
1unit |
10695 |
约6周 |
|
| ZUP-1136002 |
盐酸克林霉素 USP标准品 |
[58207-19-5] |
1unit |
10668 |
约6周 |
|
| ZUP-1210229 |
富马酸二甲酯相关化合物A USP标准品 |
[2756-87-8] |
1unit |
10668 |
约6周 |
|
| ZUP-1585028 |
吡嗪酰胺相关化合物B USP标准品 |
[19847-12-2] |
1unit |
10668 |
约6周 |
|
| ZUP-1116774 |
叶绿素a USP标准品 |
[479-61-8] |
1unit |
10626 |
约6周 |
|
| ZUP-1269141 |
泛昔洛韦相关物质F USP标准品 |
[10310-21-1] |
1unit |
10612 |
约6周 |
|
| ZUP-1012531 |
L-丙氨酰-L-丙胺酸 USP标准品 |
[1948-31-8] |
1unit |
10598 |
约6周 |
|
| ZUP-1013807 |
危险品；阿洛司琼盐酸盐 USP标准品 |
[122852-69-1] |
1unit |
10575 |
约6周 |
|
| ZUP-1A00250 |
多奈哌齐季盐 USP标准品 |
[844694-85-5] |
1unit |
10556 |
约6周 |
|
| ZUP-1044254 |
阿替洛尔相关化合物A USP标准品 |
[17194-82-0] |
1unit |
10556 |
约6周 |
|
| ZUP-1029523 |
氨氯地平相关化合物B |
[721958-72-1] |
1unit |
10528 |
约6周 |
|
| ZUP-1A13410 |
(R,R,R)-EdoxabanUSP标准品 |
[168848-20-2] |
1unit |
10528 |
约6周 |
|
| ZUP-1A06220 |
N-甲酰基多西他赛 USP标准品 |
[N/A] |
1unit |
10500 |
约6周 |
|
| ZUP-1048583 |
双-乙基乙氧苯酚甲氧苯基三嗪相关物质混合.. USP标准品 |
[N/A] |
1unit |
10500 |
约6周 |
|
| ZUP-1A20930 |
Dechloro Amlodipine (25 mg) (3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]- 4-phenyl-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) |
[88150-52-1] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13080 |
Ritonavir Divalinyl Analog (25 mg) ((2S,2'S)-N,N'-[(2S,3S,5S)-3-Hydroxy-1,6-diphenylhexane-2,5-diyl]bis(2-{3-[(2-isopropylthiazol-4-yl)methyl]-3-methylureido}-3-methylbutanamide)) |
[869368-48-9] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13850 |
Dabigatran Etexilate Methyl Ester Mesylate (25 mg) (Methyl 3-{[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino}propanoate monomethanesulfonate) |
[847785-94-8] |
1unit |
10500 |
约6周 |
|
| ZUP-1600212 |
瑞戈非尼相关化合物A USP标准品 |
[757251-39-1] |
1unit |
10500 |
约6周 |
|
| ZUP-1A01390 |
6α-羟基布地奈德 USP标准品 |
[577777-51-6] |
1unit |
10500 |
约6周 |
|
| ZUP-1A15600 |
Descyano Tofacitinib (25 mg) (1-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}ethanone) |
[477600-76-3] |
1unit |
10500 |
约6周 |
|
| ZUP-1A19600 |
N-Demethyl Bosutinib (25 mg) (4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(piperazin-1-yl)propoxy]quinoline-3-carbonitrile) |
[380843-81-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1A16500 |
N-Methyl Darunavir (25 mg) ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylamino)phenyl)sulfonamido)-1-phenylbutan-2-yl)carbamate) |
[3116821-16-7] |
1unit |
10500 |
约6周 |
|
| ZUP-1A17090 |
Darolutamide Amide (25 mg) (N-((S)-1-(3-(4-carbamoyl-3-chlorophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide) |
[3110019-44-5] |
1unit |
10500 |
约6周 |
|
| ZUP-1A16900 |
Apalutamide N-Oxide (25 mg) (2-Cyano-5-(5-(3-fluoro-4-(methylcarbamoyl)phenyl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-7-yl)-3-(trifluoromethyl)pyridine 1-oxide) |
[3110019-37-6] |
1unit |
10500 |
约6周 |
|
| ZUP-1A16890 |
Desthio N-formyl Apalutamide (25 mg) (4-(N-(1-((6-cyano-5-(trifluoromethyl)pyridin-3-yl)carbamoyl)cyclobutyl)formamido)-2-fluoro-N-methylbenzamide) |
[3110019-36-5] |
1unit |
10500 |
约6周 |
|
| ZUP-1A14090 |
Guanylmelamine Hydrochloride (25 mg) (1-(4,6-Diamino-1,3,5-triazin-2-yl)guanidine Hydrochloride) |
[2959-04-8] |
1unit |
10500 |
约6周 |
|
| ZUP-1191554 |
香风草甙 USP标准品 |
[2418540-64-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13950 |
Estradiol 3-Valerate (25 mg) (17beta-Hydroxyestra-1,3,5(10)-trien-3-yl valerate) |
[21881-45-8] |
1unit |
10500 |
约6周 |
|
| ZUP-1A14470 |
Brexpiprazole Spiro Bromide Analog (25 mg) (8-(Benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium bromide) |
[2143944-65-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13580 |
Methyl Apixaban (25 mg) (1-(4-Methoxyphenyl)-6-[4-(2-methyl-6-oxopiperidin-1-yl)phenyl]-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide) |
[2098457-92-0] |
1unit |
10500 |
约6周 |
|
| ZUP-1A19610 |
Despiperazine Bosutinib (25 mg) (4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-propoxyquinoline-3-carbonitrile) |
[2095306-25-3] |
1unit |
10500 |
约6周 |
|
| ZUP-1A12860 |
Hydroxyethylphthalimide Linagliptin (10 mg) ((R)-N1-{1-[7-(But-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}-N2-(2-hydroxyethyl)phthalamide) |
[2074688-80-3] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13760 |
Despiperazinyl Nintedanib (25 mg) (Methyl (Z)-3-{[(4-(methylamino)phenyl)amino](phenyl)methylene}-2-oxoindoline-6-carboxylate) |
[1987887-92-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1218027 |
苯海拉明相关物质B USP标准品 |
[19574-66-4] |
1unit |
10500 |
约6周 |
|
| ZUP-1A20760 |
Ezetimibe Tetrahydropyran Acid (25 mg) ((2R,3R,6S)-6-(4-Fluorophenyl)-2-(4-hydroxyphenyl)tetrahydro-2H-pyran-3-carboxylic acid) |
[1618657-31-0] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13070 |
2,5-Thiazolylmethyldicarbamate (25 mg) (Bis(thiazol-5-ylmethyl) (2S,3S,5S)-3-hydroxy-1,6-diphenylhexane-2,5-diyldicarbamate) |
[144142-33-6] |
1unit |
10500 |
约6周 |
|
| ZUP-1A15160 |
Des-(3-(Pyridin-2-ylamino)propanoate) Dabigatran Ethyl Ester Hydrochloride (25 mg) (Ethyl 2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylate hydrochloride) |
[1422435-39-9] |
1unit |
10500 |
约6周 |
|
| ZUP-1A15450 |
Dechloro Rivaroxaban (25 mg) (N-({(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide) |
[1415566-28-7] |
1unit |
10500 |
约6周 |
|
| ZUP-1A15170 |
Dabigatran Etexilate Methyl Ester (25 mg) (Methyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) |
[1408238-39-0] |
1unit |
10500 |
约6周 |
|
| ZUP-1A20510 |
N-Acetyl Duloxetine (25 mg) ((S)-N-Methyl-N-[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]acetamide) |
[1243540-90-0] |
1unit |
10500 |
约6周 |
|
| ZUP-1A02240 |
利伐沙班开放式草酰膦环USP标准品 |
[1160170-00-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13480 |
N-Acetyldespiperazinyl Nintedanib (25 mg) (Methyl (Z)-3-[{[4-(N-methylacetamido)phenyl]amino}(phenyl)methylene]-2-oxoindoline-6-carboxylate) |
[1139458-48-2] |
1unit |
10500 |
约6周 |
|
| ZUP-1A21540 |
R-Ofloxacin Q Acid (25 mg) ((3R)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
[110548-07-7] |
1unit |
10500 |
约6周 |
|
| ZUP-1A13090 |
Ritonavir Isobutoxycarbonyl Aminoalcohol (25 mg) (Thiazol-5-ylmethyl (2S,3S,5S)-(5-isobutoxycarbonylamino)-3-hydroxy-1,6-diphenylhexan-2-ylcarbamate) |
[1010809-39-8] |
1unit |
10500 |
约6周 |
|
| ZUP-1238501 |
依替巴肽 USP标准品 |
[188627-80-7] |
1unit |
10486 |
约6周 |
|
| ZUP-1076356 |
Lauryldiethanolamine USP标准品 |
[913611-97-9] |
1unit |
10485 |
约6周 |
|
| ZUP-1A10080 |
Glucotropaeolin Potassium SaltUSP标准品 |
[N/A] |
1unit |
10472 |
约6周 |
|
| ZUP-1478243 |
寡糖系统适用性混合物D USP标准品 |
[N/A] |
1unit |
10458 |
约6周 |
|
|
| |
| 共 13444 条信息 | 48-269页 |
首页 上一页 下一页 尾页 |
转到：
|
|
|
|
沪公网安备 31011202005009号